<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report a case of uveal effusion with subtotal exudative <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> induced by topical administration of travoprost </plain></SENT>
<SENT sid="1" pm="."><plain>CASE REPORT: A 20-year-old woman with a medical history of right-sided <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber-Krabbe syndrome</z:e> and bilateral <z:mp ids='MP_0003078'>aphakia</z:mp> secondary to <z:hpo ids='HP_0000519'>congenital cataract</z:hpo> extraction was referred to our department for <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> associated with uveal effusion of the right eye </plain></SENT>
<SENT sid="2" pm="."><plain>The ocular manifestations of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber-Krabbe syndrome</z:e> in her right eye were <z:hpo ids='HP_0000501'>glaucoma</z:hpo> and diffuse choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Antiglaucomatous medications using topical travoprost 0.004%/<z:chebi fb="0" ids="39465">timolol</z:chebi> 0.5% (fixed combination) had been begun 1 week before </plain></SENT>
<SENT sid="4" pm="."><plain>An adverse effect of travoprost was suspected and the drug was discontinued </plain></SENT>
<SENT sid="5" pm="."><plain>Three weeks later, a fundus examination showed total disappearance of the uveal effusion </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Interaction of the effects of topical <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> analogs (blood-aqueous barrier disruption, enhancement of uveoscleral outflow) with both the diffuse choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> and the elevated episcleral venous pressure may lead to uveal effusion in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber-Krabbe syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In spite of their efficiency, <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> F2 analogs (<z:chebi fb="0" ids="6384">latanoprost</z:chebi>, travoprost and <z:chebi fb="0" ids="51230">bimatoprost</z:chebi>) should be used with caution in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber-Krabbe syndrome</z:e> and particularly in cases of proved diffuse choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> </plain></SENT>
</text></document>